Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07571837
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical TrialAl-Azhar UniversityRecruitingNot Applicable
NCT07571837Recruiting
Not Applicable
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication...Al-Azhar University
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
NCT07570225
Innovative Non-Invasive Diagnostics and Personalized Treatment Strategies for Endometriosis Through Advanced Multi-Omics and Ultrasound IntegrationKarolinska InstitutetNot Yet Recruiting
NCT07570225Not Yet Recruiting
—
Innovative Non-Invasive Diagnostics and Personalized Treatment Strategies for En...Karolinska Institutet
NCT07570927
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine UseMasaryk UniversityCompletedNot Applicable
NCT07570927Completed
Not Applicable
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine Us...Masaryk University
NCT07569770
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Composition and Performance in Elite Rugby PlayersUniversity of TaipeiCompletedNot Applicable
NCT07569770Completed
Not Applicable
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Com...University of Taipei
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569419
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisUniversity of NottinghamRecruitingEarly Phase 1
NCT07569419Recruiting
Early Phase 1
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosi...University of Nottingham
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569536
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic ShockCentre Hospitalier Universitaire DijonNot Yet RecruitingPhase 3
NCT07569536Not Yet Recruiting
Phase 3
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in...Centre Hospitalier Univer...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07568821
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of RzeszowNot Yet RecruitingNot Applicable
NCT07568821Not Yet Recruiting
Not Applicable
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of Rzeszow
NCT07569601
The Effect of Heat Pads and Foam Rolling on Strength in Athletes.University of RedlandsActive Not RecruitingNot Applicable
NCT07569601Active Not Recruiting
Not Applicable
The Effect of Heat Pads and Foam Rolling on Strength in Athletes.University of Redlands
NCT07569965
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCLMiltenyi Biomedicine GmbHNot Yet RecruitingPhase 2
NCT07569965Not Yet Recruiting
Phase 2
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation i...Miltenyi Biomedicine GmbH
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed2 (10%)
Not Specified7 (35%)
not_applicable7 (35%)
Phase 22 (10%)
Phase 12 (10%)
Early Phase 11 (5%)
Phase 31 (5%)